Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhiyun Guo
Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Related publications
Genome‐wide Identification of a Competing Endogenous RNA Network in Cholangiocarcinoma
Journal of Cellular Biochemistry
Biochemistry
Cell Biology
Molecular Biology
TCGA Dataset‑based Construction and Integrated Analysis of Aberrantly Expressed Long Non‑coding RNA Mediated Competing Endogenous RNA Network in Gastric Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Comprehensive Analysis of the lncRNA‑associated Competing Endogenous RNA Network in Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis
Frontiers in Bioengineering and Biotechnology
Bioengineering
Biomedical Engineering
Histology
Biotechnology
LAceModule: Identification of Competing Endogenous RNA Modules by Integrating Dynamic Correlation
Frontiers in Genetics
Genetics
Molecular Medicine
Identification of a Potential Prognostic lncRNA‐miRNA‐mRNA Signature in Endometrial Cancer Based on the Competing Endogenous RNA Network
Journal of Cellular Biochemistry
Biochemistry
Cell Biology
Molecular Biology
Functional Analysis of Long Intergenic Non-Coding RNAs in Phosphate-Starved Rice Using Competing Endogenous RNA Network
Scientific Reports
Multidisciplinary
Identification of lncRNAs Associated With Lung Squamous Cell Carcinoma Prognosis in the Competitive Endogenous RNA Network
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Analysis of Competing Endogenous RNA Network and Prediction of Prognosis in Acute Lymphoblastic Leukemia Patients of Phase II and III